{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:19:23Z","timestamp":1794968363385,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K12059"],"award-info":[{"award-number":["20K12059"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most prevalent dementia disorder globally, and there are still no effective interventions for slowing or stopping the underlying pathogenic mechanisms. There is strong evidence implicating neural oxidative stress (OS) and ensuing neuroinflammation in the progressive neurodegeneration observed in the AD brain both during and prior to symptom emergence. Thus, OS-related biomarkers may be valuable for prognosis and provide clues to therapeutic targets during the early presymptomatic phase. In the current study, we gathered brain RNA-seq data of AD patients and matched controls from the Gene Expression Omnibus (GEO) to identify differentially expressed OS-related genes (OSRGs). These OSRGs were analyzed for cellular functions using the Gene Ontology (GO) database and used to construct a weighted gene co-expression network (WGCN) and protein-protein interaction (PPI) network. Receiver operating characteristic (ROC) curves were then constructed to identify network hub genes. A diagnostic model was established based on these hub genes using Least Absolute Shrinkage and Selection Operator (LASSO) and ROC analyses. Immune-related functions were examined by assessing correlations between hub gene expression and immune cell brain infiltration scores. Further, target drugs were predicted using the Drug-Gene Interaction database, while regulatory miRNAs and transcription factors were predicted using miRNet. In total, 156 candidate genes were identified among 11046 differentially expressed genes, 7098 genes in WGCN modules, and 446 OSRGs, and 5 hub genes (MAPK9, FOXO1, BCL2, ETS1, and SP1) were identified by ROC curve analyses. These hub genes were enriched in GO annotations \u201cAlzheimer\u2019s disease pathway,\u201d \u201cParkinson\u2019s Disease,\u201d \u201cRibosome,\u201d and \u201cChronic myeloid leukemia.\u201d In addition, 78 drugs were predicted to target FOXO1, SP1, MAPK9, and BCL2, including fluorouracil, cyclophosphamide, and epirubicin. A hub gene-miRNA regulatory network with 43 miRNAs and hub gene-transcription factor (TF) network with 36 TFs were also generated. These hub genes may serve as biomarkers for AD diagnosis and provide clues to novel potential treatment targets.<\/jats:p>","DOI":"10.1038\/s41598-023-34021-1","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T09:02:33Z","timestamp":1682499753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Identification of oxidative stress-related genes differentially expressed in Alzheimer\u2019s disease and construction of a hub gene-based diagnostic model"],"prefix":"10.1038","volume":"13","author":[{"given":"Yanting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanori","family":"Kiryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"issue":"2","key":"34021_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","volume":"11","author":"C Qiu","year":"2009","unstructured":"Qiu, C., Kivipelto, M. & von Strauss, E. Epidemiology of Alzheimer\u2019s disease: Occurrence, determinants, and strategies toward intervention. Dialogues Clin. Neurosci. 11(2), 111\u201328. https:\/\/doi.org\/10.31887\/DCNS.2009.11.2\/cqiu (2009).","journal-title":"Dialogues Clin. Neurosci."},{"key":"34021_CR2","unstructured":"Gauthier, S., Rosa-Neto, P., Morais, J.A. & Webster, C. World Alzheimer Report 2021: Journey Through the Diagnosis of Dementia. https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2021\/ (2021)."},{"key":"34021_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000381546","volume":"1","author":"X Chen","year":"2014","unstructured":"Chen, X. & Pan, W. The treatment strategies for neurodegenerative diseases by integrative medicine. Integr. Med. Int. 1, 223\u2013225. https:\/\/doi.org\/10.1159\/000381546 (2014).","journal-title":"Integr. Med. Int."},{"issue":"12","key":"34021_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1039\/c9md00337a","volume":"10","author":"L Blaikie","year":"2019","unstructured":"Blaikie, L., Kay, G. & Kong Thoo Lin, P. Current and emerging therapeutic targets of Alzheimer\u2019s disease for the design of multi-target directed ligands. MedChemComm 10(12), 2052\u20132072. https:\/\/doi.org\/10.1039\/c9md00337a (2019).","journal-title":"MedChemComm"},{"key":"34021_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori, I. et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging 13, 757\u2013772. https:\/\/doi.org\/10.2147\/CIA.S158513 (2018).","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"34021_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1152\/ajpregu.00327.2006","volume":"292","author":"KC Kregel","year":"2007","unstructured":"Kregel, K. C. & Zhang, H. J. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol.-Regulat. Integr. Comp. Physiol. 292(1), 18\u201336. https:\/\/doi.org\/10.1152\/ajpregu.00327.2006 (2007).","journal-title":"Am. J. Physiol.-Regulat. Integr. Comp. Physiol."},{"key":"34021_CR7","doi-asserted-by":"publisher","unstructured":"Hagen, T. M. Oxidative stress, redox imbalance, and the aging process. Antioxid Redox Signal 5(5), 503\u2013506. https:\/\/doi.org\/10.1089\/152308603770310149 (2003).","DOI":"10.1089\/152308603770310149"},{"key":"34021_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","volume":"39","author":"DC Wallace","year":"2005","unstructured":"Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359\u2013407. https:\/\/doi.org\/10.1146\/annurev.genet.39.110304.095751 (2005).","journal-title":"Annu. Rev. Genet."},{"issue":"16","key":"34021_CR9","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.1093\/emboj\/cdg417","volume":"22","author":"CM Beaus\u00e9jour","year":"2003","unstructured":"Beaus\u00e9jour, C. M. et al. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 22(16), 4212\u201322. https:\/\/doi.org\/10.1093\/emboj\/cdg417 (2003).","journal-title":"EMBO J."},{"issue":"34","key":"34021_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1089\/ars.2006.8.572","volume":"8","author":"HY Chung","year":"2006","unstructured":"Chung, H. Y., Sung, B., Jung, K. J., Zou, Y. & Yu, B. P. The molecular inflammatory process in aging. Antioxid. Redox Signal 8(34), 572\u201381. https:\/\/doi.org\/10.1089\/ars.2006.8.572 (2006).","journal-title":"Antioxid. Redox Signal"},{"issue":"1","key":"34021_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","volume":"23","author":"R William","year":"1997","unstructured":"William, R. Markesbery oxidative stress hypothesis in Alzheimer\u2019s disease. Free Radic. Biol. Med. 23(1), 134\u2013147. https:\/\/doi.org\/10.1016\/S0891-5849(96)00629-6 (1997).","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"34021_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","volume":"1502","author":"MA Smith","year":"2000","unstructured":"Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K. & Perry, G. Oxidative stress in Alzheimer\u2019s disease. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 1502(1), 139\u2013144. https:\/\/doi.org\/10.1016\/S0925-4439(00)00040-5 (2000).","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"34021_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/316523","volume":"2013","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. & Zhao, B. Oxidative stress and the pathogenesis of Alzheimer\u2019s disease. Oxid. Med. Cell Longev. 2013, 316523. https:\/\/doi.org\/10.1155\/2013\/316523 (2013).","journal-title":"Oxid. Med. Cell Longev."},{"issue":"9","key":"34021_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s0891-5849(02)00780-3","volume":"32","author":"MF Beal","year":"2002","unstructured":"Beal, M. F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 32(9), 797\u2013803. https:\/\/doi.org\/10.1016\/s0891-5849(02)00780-3 (2002).","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"34021_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s11064-008-9808-4","volume":"34","author":"E Head","year":"2008","unstructured":"Head, E. Oxidative damage and cognitive dysfunction: Antioxidant treatments to promote healthy brain aging. Antioxid. Redox Signal 34(4), 670\u20138. https:\/\/doi.org\/10.1007\/s11064-008-9808-4 (2008).","journal-title":"Antioxid. Redox Signal"},{"issue":"2","key":"34021_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3233\/jad-2004-6209","volume":"6","author":"D Pratic\u00f3","year":"2014","unstructured":"Pratic\u00f3, D. & Sung, S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer\u2019s disease. Oxid. Med. Cell. Longev. 6(2), 171\u2013175. https:\/\/doi.org\/10.3233\/jad-2004-6209 (2014).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"34021_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neurobiolaging.2005.06.004","volume":"27","author":"TI Williams","year":"2006","unstructured":"Williams, T. I., Lynn, B. C., Markesbery, W. R. & Lovell, M. A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer\u2019s disease. Neurobiol. Aging 27(8), 1094\u20139. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2005.06.004 (2006).","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"34021_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0891988710383571","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris, L. M., Yu, C. E., Bird, T. D. & Tsuang, D. W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 23(4), 213\u201327. https:\/\/doi.org\/10.1177\/0891988710383571 (2010).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"34021_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.949083","volume":"14","author":"X Gu","year":"2022","unstructured":"Gu, X. et al. Hub genes, diagnostic model, and predicted drugs related to iron metabolism in Alzheimer\u2019s disease. Front Aging Neurosci. 14, 949083. https:\/\/doi.org\/10.3389\/fnagi.2022.949083 (2022).","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"34021_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","volume":"69","author":"MA Ansari","year":"2010","unstructured":"Ansari, M. A. & Scheff, S. W. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J. Neuropathol. Exp. Neurol. 69(2), 155\u201367. https:\/\/doi.org\/10.1097\/NEN.0b013e3181cb5af4 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"11\u201312","key":"34021_CR21","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1089\/ars.2006.8.2039","volume":"8","author":"WR Markesbery","year":"2006","unstructured":"Markesbery, W. R. & Lovell, M. A. DNA oxidation in Alzheimer\u2019s disease. Antioxid. Redox Signal 8(11\u201312), 2039\u201345. https:\/\/doi.org\/10.1089\/ars.2006.8.2039 (2006).","journal-title":"Antioxid. Redox Signal"},{"issue":"8","key":"34021_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.freeradbiomed.2008.01.002","volume":"44","author":"PI Moreira","year":"2008","unstructured":"Moreira, P. I. et al. Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 44(8), 1493\u2013505. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.01.002 (2008).","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"34021_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/0971-5916.93430","volume":"35","author":"M Kumar","year":"2012","unstructured":"Kumar, M. et al. Chromosomal abnormalities and oxidative stress in women with premature ovarian failure (POF). Indian J. Med. Res. 35(1), 92\u20137. https:\/\/doi.org\/10.4103\/0971-5916.93430 (2012).","journal-title":"Indian J. Med. Res."},{"issue":"6","key":"34021_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/ana.410400619","volume":"40","author":"TD Bird","year":"1996","unstructured":"Bird, T. D. et al. Wide range in age of onset for chromosome 1-related familial Alzheimer\u2019s disease. Ann. Neurol. 40(6), 932\u20136. https:\/\/doi.org\/10.1002\/ana.410400619 (1996).","journal-title":"Ann. Neurol."},{"issue":"3","key":"34021_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/s0006-3223(99)00301-7","volume":"47","author":"PH St George-Hyslop","year":"2000","unstructured":"St George-Hyslop, P. H. Molecular genetics of Alzheimer\u2019s disease. Biol. Psychiatry 47(3), 483\u201399. https:\/\/doi.org\/10.1016\/s0006-3223(99)00301-7 (2000).","journal-title":"Biol. Psychiatry"},{"key":"34021_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1001130","volume":"6","author":"C Naj Adam","year":"2010","unstructured":"Naj Adam, C. et al. Dementia revealed: Novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities. PLOS Genet. 6, 1\u201310. https:\/\/doi.org\/10.1371\/journal.pgen.1001130 (2010).","journal-title":"PLOS Genet."},{"issue":"51","key":"34021_CR27","doi-asserted-by":"publisher","first-page":"49782","DOI":"10.1074\/jbc.M206448200","volume":"277","author":"A Rostagno","year":"2002","unstructured":"Rostagno, A. et al. Complement activation in chromosome 13 dementias. similarities with Alzheimer\u2019s disease. J. Biol. Chem. 277(51), 49782\u201390. https:\/\/doi.org\/10.1074\/jbc.M206448200 (2002).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"34021_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/jpm11121275","volume":"11","author":"A Turk","year":"2021","unstructured":"Turk, A., Kunej, T. & Peterlin,. MicroRNA-target interaction regulatory network in Alzheimer\u2019s disease. J. Pers. Med. 11(12), 1275. https:\/\/doi.org\/10.3390\/jpm11121275 (2021).","journal-title":"J. Pers. Med."},{"issue":"4\u20135","key":"34021_CR29","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.brainresbull.2009.08.006","volume":"80","author":"X Wang","year":"2009","unstructured":"Wang, X. et al. MIR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer\u2019s disease, inhibits bcl2 translation. Brain Res. Bull. 80(4\u20135), 268\u2013273. https:\/\/doi.org\/10.1016\/j.brainresbull.2009.08.006 (2009).","journal-title":"Brain Res. Bull."},{"issue":"3","key":"34021_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3233\/JAD-122263","volume":"35","author":"C Villa","year":"2013","unstructured":"Villa, C. et al. Expression of the transcription factor sp1 and its regulatory HSA-MIR-29b in peripheral blood mononuclear cells from patients with Alzheimer\u2019s disease. J. Alzheimer\u2019s Dis. 35(3), 487\u2013494. https:\/\/doi.org\/10.3233\/JAD-122263 (2013).","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"10","key":"34021_CR31","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1002\/emmm.201201974","volume":"5","author":"P Lau","year":"2013","unstructured":"Lau, P. et al. Alteration of the microRNA network during the progression of Alzheimer\u2019s disease. EMBO Mol. Med. 5(10), 1613\u201334. https:\/\/doi.org\/10.1002\/emmm.201201974 (2013).","journal-title":"EMBO Mol. Med."},{"key":"34021_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000067426","volume":"11","author":"X Zhu","year":"2002","unstructured":"Zhu, X., Lee, H.-G., Raina, A. K., Perry, G. & Smith, M. A. The role of mitogen-activated protein kinase pathways in Alzheimer\u2019s disease. Neurosignals 11, 270\u2013281. https:\/\/doi.org\/10.1159\/000067426 (2002).","journal-title":"Neurosignals"},{"issue":"6","key":"34021_CR33","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.3390\/cells10061410","volume":"10","author":"BL Santos-Lobato","year":"2021","unstructured":"Santos-Lobato, B. L., Vidal, A. F. & Ribeiro-Dos-Santos, \u00c2. Regulatory miRNA-mRNA networks in Parkinson\u2019s disease. Cells 10(6), 1410. https:\/\/doi.org\/10.3390\/cells10061410 (2021).","journal-title":"Cells"},{"issue":"3","key":"34021_CR34","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/039463200601900322","volume":"19","author":"R Bei","year":"2006","unstructured":"Bei, R. et al. Immunity to extracellular matrix antigens is associated with ultrastructural alterations of the stroma and stratified epithelium basement membrane in the skin of hashimotos thyroiditis patients. Int. J. Immunopathol. Pharmacol. 19(3), 661\u201374. https:\/\/doi.org\/10.1177\/039463200601900322 (2006).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"34021_CR35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF03033913","volume":"12","author":"Q Niu","year":"2007","unstructured":"Niu, Q., Yang, Y. & Zhang, Qea. The relationship between bcl-2 gene expression and learning & memory impairment in chronic aluminum-exposed rats. Neurotox Res. 12, 163\u2013169. https:\/\/doi.org\/10.1007\/BF03033913 (2007).","journal-title":"Neurotox Res."},{"issue":"1","key":"34021_CR36","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/205873920601900124","volume":"19","author":"F Midulla","year":"2006","unstructured":"Midulla, F. et al. Cytokines in the nasal washes of children with respiratory syncytial virus bronchiolitis. Int. J. Immunopathol. Pharmacol. 19(1), 231\u2013235 (2006).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"34021_CR37","doi-asserted-by":"publisher","first-page":"7619255","DOI":"10.1155\/2022\/7619255","volume":"2022","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Cross-talking pathways of forkhead box o1 (foxo1) are involved in the pathogenesis of Alzheimer\u2019s disease and Huntington\u2019s disease. Oxid. Med. Cell Longev. 2022, 7619255. https:\/\/doi.org\/10.1155\/2022\/7619255 (2022).","journal-title":"Oxid. Med. Cell Longev."},{"issue":"2","key":"34021_CR38","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4161\/auto.27003","volume":"10","author":"SH Tan","year":"2014","unstructured":"Tan, S. H. et al. Critical role of scd1 in autophagy regulation via lipogenesis and lipid rafts-coupled akt-foxo1 signaling pathway. Autophagy 10(2), 226\u201342. https:\/\/doi.org\/10.4161\/auto.27003 (2014).","journal-title":"Autophagy"},{"issue":"2","key":"34021_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3233\/JAD-122191","volume":"37","author":"N Jantaratnotai","year":"2013","unstructured":"Jantaratnotai, N. et al. Upregulation and expression patterns of the angiogenic transcription factor Ets-1 in Alzheimer\u2019s disease brain. J Alzheimers Dis 37(2), 367\u201377. https:\/\/doi.org\/10.3233\/JAD-122191 (2013).","journal-title":"J Alzheimers Dis"},{"key":"34021_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"E Gjoneska","year":"2015","unstructured":"Gjoneska, E. et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease. Nature 518, 365\u2013369. https:\/\/doi.org\/10.1038\/nature14252 (2015).","journal-title":"Nature"},{"issue":"11","key":"34021_CR41","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/jnr.21695","volume":"86","author":"BA Citron","year":"2008","unstructured":"Citron, B. A., Dennis, J. S., Zeitlin, R. S. & Echeverria, V. Transcription factor sp1 dysregulation in Alzheimer\u2019s disease. J. Neurosci. Res. 86(11), 2499\u2013504. https:\/\/doi.org\/10.1002\/jnr.21695 (2008).","journal-title":"J. Neurosci. Res."},{"issue":"1\u20132","key":"34021_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.neulet.2005.11.062","volume":"397","author":"G Santpere","year":"2006","unstructured":"Santpere, G., Nieto, M., Puig, B. & Ferrer, I. Abnormal sp1 transcription factor expression in Alzheimer disease and tauopathies. Neurosci. Lett. 397(1\u20132), 30\u201334. https:\/\/doi.org\/10.1016\/j.neulet.2005.11.062 (2006).","journal-title":"Neurosci. Lett."},{"issue":"5","key":"34021_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/s1534-5807(03)00323-x","volume":"5","author":"MC Wang","year":"2003","unstructured":"Wang, M. C., Bohmann, D. & Jasper, H. JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila. Dev. Cell 5(5), 811\u20136. https:\/\/doi.org\/10.1016\/s1534-5807(03)00323-x (2003).","journal-title":"Dev. Cell"},{"issue":"12","key":"34021_CR44","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1073\/pnas.0500749102","volume":"102","author":"SW Oh","year":"2005","unstructured":"Oh, S. W. et al. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor\/DAF-16. Proc. Natl. Acad. Sci. USA 102(12), 4494\u20139. https:\/\/doi.org\/10.1073\/pnas.0500749102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8\u20139","key":"34021_CR45","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/s0531-5565(02)00082-7","volume":"37","author":"HJ Kim","year":"2002","unstructured":"Kim, H. J., Jung, K. J., Yu, B. P., Cho, C. G. & Chung, H. Y. Influence of aging and calorie restriction on MAPKS activity in rat kidney. Exp. Gerontol. 37(8\u20139), 1041\u201353. https:\/\/doi.org\/10.1016\/s0531-5565(02)00082-7 (2002).","journal-title":"Exp. Gerontol."},{"issue":"2","key":"34021_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/00001756-199601310-00015","volume":"7","author":"JH Su","year":"1996","unstructured":"Su, J. H., Satou, T., Anderson, A. J. & Cotman, C. W. Up-regulation of Bcl-2 is associated with neuronal DNA damage in Alzheimer\u2019s disease. Neuroreport 7(2), 437\u201340. https:\/\/doi.org\/10.1097\/00001756-199601310-00015 (1996).","journal-title":"Neuroreport"},{"issue":"6","key":"34021_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2021.118997","volume":"1868","author":"Manon Callens","year":"2021","unstructured":"Callens, Manon et al. The role of Bcl-2 proteins in modulating neuronal Ca$$^2+$$ signaling in health and in Alzheimer\u2019s disease. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1868(6), 118997. https:\/\/doi.org\/10.1016\/j.bbamcr.2021.118997 (2021).","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"11","key":"34021_CR48","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/mp.2010.17","volume":"15","author":"KN Manolopoulos","year":"2010","unstructured":"Manolopoulos, K. N., Klotz, L. O., Korsten, P., Bornstein, S. R. & Barthel, A. Linking Alzheimer\u2019s disease to insulin resistance: The foxo response to oxidative stress. Mol. Psychiatry 15(11), 1046\u201352. https:\/\/doi.org\/10.1038\/mp.2010.17 (2010).","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"34021_CR49","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s00018-022-04230-4","volume":"79","author":"BR Gehi","year":"2022","unstructured":"Gehi, B. R., Gadhave, K., Uversky, V. N. & Giri, R. Intrinsic disorder in proteins associated with oxidative stress-induced JNK signaling. Cell Mol. Life Sci. 79(4), 202. https:\/\/doi.org\/10.1007\/s00018-022-04230-4 (2022).","journal-title":"Cell Mol. Life Sci."},{"issue":"7","key":"34021_CR50","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","volume":"87","author":"K Sinha","year":"2013","unstructured":"Sinha, K., Das, J., Pal, P. B. & Sil, P. C. Oxidative stress: The mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch. Toxicol. 87(7), 1157\u201380. https:\/\/doi.org\/10.1007\/s00204-013-1034-4 (2013).","journal-title":"Arch. Toxicol."},{"key":"34021_CR51","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3389\/fnagi.2019.00243","volume":"11","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Appoptosin mediates lesions induced by oxidative stress through the JNK\u2013Foxo1 pathway. Front. Aging Neurosci. 11, 243. https:\/\/doi.org\/10.3389\/fnagi.2019.00243 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"34021_CR52","unstructured":"Citron, B. A., Saykally, J. N., Cao, C., Dennis, J. S., Runfeldt, M. & Arendash, G. W. Transcription factor sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer\u2019s disease. Am. J. Neurodegener. Dis. 4(2), 40\u201348 (2015)."},{"key":"34021_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12041-021-01260-y","volume":"100","author":"GKEI Udayaraja","year":"2021","unstructured":"Udayaraja, G. K. E. I. Network-based gene deletion analysis identifies candidate genes and molecular mechanism involved in clear cell renal cell carcinoma. J. Genet. 100, 1 (2021).","journal-title":"J. Genet."},{"issue":"1","key":"34021_CR54","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"YHY Benjamini","year":"1995","unstructured":"Benjamini, Y. H. Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57(1), 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B"},{"key":"34021_CR55","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: An r package for weighted correlation network analysis. BMC Bioinform. 9, 559. https:\/\/doi.org\/10.1186\/1471-2105-9-559 (2008).","journal-title":"BMC Bioinform."},{"key":"34021_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng, F. & Edison, P. Neuroinflammation and microglial activation in Alzheimer disease: Where do we go from here?. Nat. Rev. Neurol. 17, 157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"34021_CR57","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang, L., Zhou, G., Soufan, O. & Xia, J. miRNet 2.0: Network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 48, 244\u2013251. https:\/\/doi.org\/10.1093\/nar\/gkaa467 (2020).","journal-title":"Nucleic Acids Res."},{"key":"34021_CR58","doi-asserted-by":"publisher","unstructured":"Cotto, K. C. et al. Dgidb 3.0: A redesign and expansion of the drug\u2013gene interaction database. Nucleic Acids Res. 4, 46. https:\/\/doi.org\/10.1093\/nar\/gkx1143 (2018).","DOI":"10.1093\/nar\/gkx1143"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34021-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34021-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T06:26:14Z","timestamp":1729319174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34021-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34021-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"24 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6817"}}